New eye drop combo aims to lower pressure in glaucoma patients
NCT ID NCT07354516
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 4 times
Summary
This study tests a new preservative-free eye drop combination (QLS-111-FDC) to lower eye pressure in people with open-angle glaucoma or ocular hypertension. About 60 adults with mild to moderate disease will receive the treatment. The goal is to see if it safely reduces eye pressure better than current options.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OAG - OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shettle Eye Research
Largo, Florida, 33773, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.